CR9908A - Metodo para la anticoncepcion hormonal preventiva bajo demanda - Google Patents
Metodo para la anticoncepcion hormonal preventiva bajo demandaInfo
- Publication number
- CR9908A CR9908A CR9908A CR9908A CR9908A CR 9908 A CR9908 A CR 9908A CR 9908 A CR9908 A CR 9908A CR 9908 A CR9908 A CR 9908A CR 9908 A CR9908 A CR 9908A
- Authority
- CR
- Costa Rica
- Prior art keywords
- preventive
- under demand
- demand
- hormonal anti
- conception under
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
La invencion se relaciona con un metodo de anticoncepcion hormonal femenina controlada bajo demanda que comprende administrar una preparacion farmaceutica que comprende al menos un gestageno por via transdermica, bajo demanda y en una sola ocasion, en anticipacion del encuentro sexual.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005050729A DE102005050729A1 (de) | 2005-10-19 | 2005-10-19 | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9908A true CR9908A (es) | 2008-05-21 |
Family
ID=37762565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9908A CR9908A (es) | 2005-10-19 | 2008-04-21 | Metodo para la anticoncepcion hormonal preventiva bajo demanda |
Country Status (13)
Country | Link |
---|---|
US (3) | US20080311180A1 (es) |
EP (1) | EP1937275A1 (es) |
JP (2) | JP2009512658A (es) |
KR (1) | KR20080056774A (es) |
CN (1) | CN101340915A (es) |
BR (1) | BRPI0617683A2 (es) |
CA (1) | CA2626567C (es) |
CR (1) | CR9908A (es) |
DE (1) | DE102005050729A1 (es) |
EC (1) | ECSP088390A (es) |
GT (1) | GT200800038A (es) |
HN (1) | HN2008000621A (es) |
WO (1) | WO2007045513A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2710293A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
CA2758764C (en) * | 2009-04-14 | 2017-04-11 | Elizabeth Gray Raymond | Method for on-demand contraception using levonorgestrel or norgestrel |
CA2757496A1 (en) | 2009-04-14 | 2010-10-21 | Andre Ulmann | Method for on-demand contraception |
DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CN104797258A (zh) | 2012-11-22 | 2015-07-22 | 拜耳药业股份公司 | 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法 |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
TN2015000511A1 (en) | 2013-05-23 | 2017-04-06 | Bayer Pharma AG | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
MX2016014281A (es) | 2014-05-22 | 2017-02-22 | Therapeuticsmd Inc | Formulaciones y terapias de reemplazo de combinación de hormonas naturales. |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5512292A (en) * | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
DE4229820C2 (de) * | 1992-09-07 | 1998-12-03 | Jenapharm Gmbh | Pharmazeutische Zubereitung auf Gestagen-Basis |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
IL115738A (en) * | 1994-10-24 | 2002-05-23 | Schering Ag | Competitive progesterone antibodies to regulate female fertility as required |
PL353994A1 (en) * | 1999-08-31 | 2003-12-15 | Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
AU2003245252A1 (en) * | 2002-04-30 | 2003-11-17 | Fmc Corporation | Carrageenan based antimicrobial compositions |
UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
MXPA06006682A (es) * | 2003-12-12 | 2006-08-11 | Schering Ag | Hormonas de administracion transdermica que no necesitan potenciadores de penetracion. |
-
2005
- 2005-10-19 DE DE102005050729A patent/DE102005050729A1/de not_active Withdrawn
-
2006
- 2006-10-19 WO PCT/EP2006/010273 patent/WO2007045513A1/de active Application Filing
- 2006-10-19 CA CA2626567A patent/CA2626567C/en not_active Expired - Fee Related
- 2006-10-19 CN CNA2006800480426A patent/CN101340915A/zh active Pending
- 2006-10-19 EP EP06828860A patent/EP1937275A1/de not_active Withdrawn
- 2006-10-19 JP JP2008535989A patent/JP2009512658A/ja not_active Withdrawn
- 2006-10-19 US US12/090,719 patent/US20080311180A1/en not_active Abandoned
- 2006-10-19 BR BRPI0617683-6A patent/BRPI0617683A2/pt not_active IP Right Cessation
- 2006-10-19 KR KR1020087011824A patent/KR20080056774A/ko not_active Application Discontinuation
- 2006-10-19 US US11/583,143 patent/US20070111976A1/en not_active Abandoned
-
2008
- 2008-04-18 GT GT200800038A patent/GT200800038A/es unknown
- 2008-04-21 HN HN2008000621A patent/HN2008000621A/es unknown
- 2008-04-21 EC EC2008008390A patent/ECSP088390A/es unknown
- 2008-04-21 CR CR9908A patent/CR9908A/es not_active Application Discontinuation
-
2012
- 2012-05-29 US US13/482,023 patent/US20130089574A1/en not_active Abandoned
-
2013
- 2013-09-24 JP JP2013197047A patent/JP2014001239A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20080311180A1 (en) | 2008-12-18 |
CN101340915A (zh) | 2009-01-07 |
JP2009512658A (ja) | 2009-03-26 |
HN2008000621A (es) | 2011-07-22 |
BRPI0617683A2 (pt) | 2011-08-02 |
US20130089574A1 (en) | 2013-04-11 |
WO2007045513A1 (de) | 2007-04-26 |
CA2626567C (en) | 2013-12-03 |
DE102005050729A1 (de) | 2007-04-26 |
EP1937275A1 (de) | 2008-07-02 |
GT200800038A (es) | 2009-04-01 |
JP2014001239A (ja) | 2014-01-09 |
KR20080056774A (ko) | 2008-06-23 |
ECSP088390A (es) | 2008-05-30 |
CA2626567A1 (en) | 2007-04-26 |
US20070111976A1 (en) | 2007-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9908A (es) | Metodo para la anticoncepcion hormonal preventiva bajo demanda | |
CR7022A (es) | Productos esteroides hormonales y metodos para su preparacion | |
HN2001000266A (es) | Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis. | |
GT200800205A (es) | Metodos par la prevención y tratamiento de condiciones que surgen de deficiencia de estrogeno local | |
AR032204A1 (es) | Complejos de inclusion de ciclodextrina-drospirenona | |
ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
UY30333A1 (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual | |
PL1845957T3 (pl) | Sposób uzyskiwania ekstraktu leku zawierającego hydroksystylben | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
CR11493A (es) | Sistema de administracion vaginal | |
BR122019021238B8 (pt) | uso de um inibidor do receptor da interleucina-6 (il-6) no tratamento da doença do enxerto versus hospedeiro (gvhd) | |
AR057946A1 (es) | Formulacion de zonisamida de liberacion sostenidda | |
DOP2006000223A (es) | Procedimiento para la produccion de una preparacion farmacéutica monofasica para la terapia oral de la hemorragia uterina disfuncional. | |
ECSP10010224A (es) | Formulaciones líquidas de hormona luteinizante (lh). | |
UA95447C2 (ru) | Способ женской контрацепции | |
CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
CL2011003113A1 (es) | Composicion adyuvante acuosa que comprende un agonista de tlr-4 y una saponina y un agente de isotonicidad no ionico; proceso para la preparacion de una composicion inmunogenica. | |
ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
AR049065A1 (es) | Forma de administracion para la contracepcion hormonal | |
CL2012001671A1 (es) | Compuestos derivados de (metilsulfonil)-etil-bencenoisoindolina; composicion farmaceutica que los comprende, uso en el tratamiento del cancer, dolor, trastornos del snc, enfermedades dermatologicas, entre otras. | |
CO2019000604A2 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d | |
CL2012003105A1 (es) | Bacteria comensal geneticamente diseñada, del tracto genital femenino que expresa un agente anti espermatozoide; composicion que comprende dicha bacteria; uso de dicha composicion para la reduccion de la incidencia de embarazo en una poblacion femenina; dispositivo de insercion intravaginal. | |
PE20090805A1 (es) | COMBINACION DE DROSPIRENONA Y 17ß-ESTRADIOL COMO CONTRACEPTIVO ORAL | |
BRPI0513186A (pt) | composição medicinal para a administração oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |